Skip to main content

Sangamo Therapeutics, Inc 10-Q for FY2026 Q1

Sangamo Therapeutics, Inc (SGMOQ)

10-Q 2026-05-14 For: 2026-03-31
View Original
Added on May 16, 2026

About this 10-Q

Sangamo Therapeutics, Inc filed this 10-Q on May 14, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.44M
down 77.6% from $6.44M a year earlier
Net loss
$31M
compared with a net loss of $30.6M a year earlier
Diluted EPS
-$0.08
compared with -$0.14 a year earlier